BDBM755769 N-(1-((1-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)piperidin-4-yl)methyl)piperidin-4-yl)-4-((4-(((3-(N-methylmethylsulfonamido)pyrazin-2-yl)methyl)amino)-5-(trifluoromethyl)pyrimidin-2-yl)amino)benzamide::US20250214967, Compound A4

SMILES CN(c1nccnc1CNc1nc(Nc2ccc(C(=O)NC3CCN(CC4CCN(c5ccc6c(c5)C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)CC3)cc2)ncc1C(F)(F)F)S(C)(=O)=O

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 755769   

TargetFocal adhesion kinase 1(Human)TBA
LigandPNGBDBM755769(N-(1-((1-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoiso...)
Affinity DataIC50: 0.400nMAssay Description:The inhibitory activity of a compound against FAK was determined in a buffer containing 5 mM HEPES, pH 7.5, 0.01% Triton, 0.5 mM EGTA, and 0.01% BRIJ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent